CASP9 and inflammatory bowel disease: The concentrations of caspase 9 were significantly lower in LE-PBMCs from IBD patients than controls (5.12 ng/ml (2.54-10.42) vs. 76.3 ng/ml (16.8-346.5), p<0.001), regardless the disease type and without significant difference between CD and UC (Figure 4).